B38-CAP is a bacteria-derived ACE2-like enzyme that downregulates Ang II levels in mice and suppresses Ang II-induced hypertension, pathological cardiac hypertrophy, and myocardial fibrosis [107]. The gene discussed is AGT; the disease is hypertensive disorder.